Spineway S.A (ALSPW) | Stock Overview & Key Data
Spineway S.A. | Small-cap | Healthcare
Spineway S.A. | Small-cap | Healthcare
Spineway S.A Performance Comparison
Stock Range
Today's Range
Low: €0.13
High: €0.13
on August 22, 2025
52 Week Range
Low: €0.07
High: €0.65
on November 26, 2024
on August 30, 2024
All-Time High: €0.15 on June 10, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€4.5M
EPS
0.00
P/E Ratio (TTM)
0.02
Forward P/E
4.26
P/B Ratio
0.18
PEG Ratio
4.26
Div. Yield
N/A
ROE
-8.42%
Beta
0.803
Debt to Equity
6.46
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-20.87%
Profit Margin
-16.10%
Returns and Earnings
Return on Assets (TTM)
-2.79%
Return on Equity (TTM)
-8.42%
EBITDA
€-907.0K
Net Income (TTM)
€-1.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.59
Quarterly Revenue Growth (YoY)
-14.00%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Spineway S.A ALSPW | 4.54M Small-cap | 0.00% | 8.33% | 8.33% | 8.33% | 44.44% | 8.33% | 8.33% | 8.33% |
| EssilorLuxottica EL | 123.50B Large-cap | 1.68% | 12.26% | 3.58% | -5.36% | 16.14% | 26.57% | 79.07% | 139.75% |
| Sartorius Stedim DIM | 17.27B Large-cap | 0.25% | 1.63% | -9.07% | -12.99% | -3.92% | 0.23% | -53.00% | -40.00% |
| Crossject S.A ALCJ | 85.42M Small-cap | 2.44% | 4.35% | -1.18% | -6.67% | -25.00% | -28.51% | -56.70% | -55.79% |
| Visiomed Group SA ALVMG | 53.17M Small-cap | 5.00% | 10.53% | 16.67% | 0.00% | 23.53% | 23.53% | -48.78% | -80.19% |
| Bonyf N.V MLBON | 7.77M Small-cap | 0.00% | 0.00% | -18.35% | -30.27% | -28.33% | -19.38% | 7.50% | 3.20% |
Ownership & Short Interest
Insider Ownership
0.00%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
364K
Average 90-Day Volume
564K
Spineway S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Spineway S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALSPW's 52-week high and low?
- In the last 52 weeks, Spineway S.A reached a high of €0.65 (on August 30, 2024) and a low of €0.07 (on November 26, 2024).
- What is the market cap and P/E ratio for ALSPW?
- Curious about Spineway S.A's size and valuation? Its market capitalization stands at 4.54M. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.02, and the forward P/E (looking ahead) is 4.26.
- Does ALSPW pay dividends? If so, what's the yield?
- As for dividends, Spineway S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Spineway S.A's main competitors or similar companies to consider before investing?
When looking at Spineway S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return EssilorLuxottica
EL123.50B Healthcare Medical Instruments & Supplies 26.57% 79.07% Sartorius Stedim
DIM17.27B Healthcare Medical Instruments & Supplies 0.23% -53.00% Crossject S.A
ALCJ85.42M Healthcare Medical Instruments & Supplies -28.51% -56.70% Visiomed Group SA
ALVMG53.17M Healthcare Medical Instruments & Supplies 23.53% -48.78% Bonyf N.V
MLBON7.77M Healthcare Medical Instruments & Supplies -19.38% 7.50% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Spineway S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Spineway S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -8.42%, the Debt to Equity ratio from the most recent quarter is 6.46, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALSPW?
- Looking at Spineway S.A's growth, its revenue over the trailing twelve months (TTM) was €12M. Compared to the same quarter last year (YoY), quarterly revenue grew by -14.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALSPW stock is held by insiders and institutions?
- Wondering who owns Spineway S.A stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.